"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ARDX. [ FAQ on what and how to ask] For non-ARDX questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Michael G. Raab
Headquarter: 400 Fifth Avenue, Suite 210, Waltham, MA, United States, 02451
Industry: Biotechnology, Investment Track: GLP-1 for Weight Loss, Employees: 489
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
My Watchlist
